These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23416515)

  • 1. Endogenous CGRP protects against neointimal hyperplasia following wire-induced vascular injury.
    Yang L; Sakurai T; Kamiyoshi A; Ichikawa-Shindo Y; Kawate H; Yoshizawa T; Koyama T; Iesato Y; Uetake R; Yamauchi A; Tanaka M; Toriyama Y; Igarashi K; Shindo T
    J Mol Cell Cardiol; 2013 Jun; 59():55-66. PubMed ID: 23416515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT4 deficiency protects against neointima formation following arterial injury in mice.
    Lv L; Meng Q; Ye M; Wang P; Xue G
    J Mol Cell Cardiol; 2014 Sep; 74():284-94. PubMed ID: 24933129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation.
    Duran-Prado M; Morell M; Delgado-Maroto V; Castaño JP; Aneiros-Fernandez J; de Lecea L; Culler MD; Hernandez-Cortes P; O'Valle F; Delgado M
    Circ Res; 2013 May; 112(11):1444-55. PubMed ID: 23595952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of Long Pentraxin PTX3 Promoted Neointimal Hyperplasia after Vascular Injury.
    Ishino M; Shishido T; Suzuki S; Katoh S; Sasaki T; Funayama A; Netsu S; Hasegawa H; Honda S; Takahashi H; Arimoto T; Miyashita T; Miyamoto T; Watanabe T; Takeishi Y; Kubota I
    J Atheroscler Thromb; 2015; 22(4):372-8. PubMed ID: 25342475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular injury activates the ELK1/SND1/SRF pathway to promote vascular smooth muscle cell proliferative phenotype and neointimal hyperplasia.
    Su C; Liu M; Yao X; Hao W; Ma J; Ren Y; Gao X; Xin L; Ge L; Yu Y; Wei M; Yang J
    Cell Mol Life Sci; 2024 Jan; 81(1):59. PubMed ID: 38279051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells.
    Kim HJ; Yoo EK; Kim JY; Choi YK; Lee HJ; Kim JK; Jeoung NH; Lee KU; Park IS; Min BH; Park KG; Lee CH; Aronow BJ; Sata M; Lee IK
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1558-64. PubMed ID: 19696405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury.
    Hirata Y; Kurobe H; Nishio C; Tanaka K; Fukuda D; Uematsu E; Nishimoto S; Soeki T; Harada N; Sakaue H; Kitagawa T; Shimabukuro M; Nakaya Y; Sata M
    Eur J Pharmacol; 2013 Jan; 699(1-3):106-11. PubMed ID: 23220706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of vascular smooth muscle cell proliferation and migration in vitro and neointimal hyperplasia in vivo by adenoviral-mediated atrial natriuretic peptide delivery.
    Larifla L; Déprez I; Pham I; Rideau D; Louzier V; Adam M; Eloit M; Foucan L; Adnot S; Teiger E
    J Gene Med; 2012 Jul; 14(7):459-67. PubMed ID: 22645072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide inhibits neointimal hyperplasia following vascular injury via differential, cell-specific modulation of SOD-1 in the arterial wall.
    Bahnson ES; Koo N; Cantu-Medellin N; Tsui AY; Havelka GE; Vercammen JM; Jiang Q; Kelley EE; Kibbe MR
    Nitric Oxide; 2015 Jan; 44():8-17. PubMed ID: 25460325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging exacerbates neointimal formation, and increases proliferation and reduces susceptibility to apoptosis of vascular smooth muscle cells in mice.
    Vazquez-Padron RI; Lasko D; Li S; Louis L; Pestana IA; Pang M; Liotta C; Fornoni A; Aitouche A; Pham SM
    J Vasc Surg; 2004 Dec; 40(6):1199-207. PubMed ID: 15622375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
    Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC
    Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin-3A protects against neointimal hyperplasia after vascular injury.
    Wu JH; Zhou YF; Hong CD; Chen AQ; Luo Y; Mao L; Xia YP; He QW; Jin HJ; Huang M; Li YN; Hu B
    EBioMedicine; 2019 Jan; 39():95-108. PubMed ID: 30579864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular gene transfer of CGRP inhibits neointimal hyperplasia after balloon injury in the rat abdominal aorta.
    Wang W; Sun W; Wang X
    Am J Physiol Heart Circ Physiol; 2004 Oct; 287(4):H1582-9. PubMed ID: 15371265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of vascular smooth muscle cell proliferation in vitro by genetically engineered marrow stromal cells secreting calcitonin gene-related peptide.
    Deng W; St Hilaire RC; Chattergoon NN; Jeter JR; Kadowitz PJ
    Life Sci; 2006 Mar; 78(16):1830-8. PubMed ID: 16325211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A₂B receptor agonism inhibits neointimal lesion development after arterial injury in apolipoprotein E-deficient mice.
    Bot I; de Vries H; Korporaal SJ; Foks AC; Bot M; van Veldhoven J; Ter Borg MN; van Santbrink PJ; van Berkel TJ; Kuiper J; Ijzerman AP
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2197-205. PubMed ID: 22743060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin gene-related peptide inhibits angiotensin II-induced NADPH oxidase-dependent ROS via the Src/STAT3 signalling pathway.
    Luo HM; Wu X; Xian X; Wang LY; Zhu LY; Sun HY; Yang L; Liu WX
    J Cell Mol Med; 2020 Jun; 24(11):6426-6437. PubMed ID: 32372557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of tumour necrosis factor-alpha and interferon-gamma in bone marrow cells synergistically inhibits neointimal formation following vascular injury.
    Murayama H; Takahashi M; Takamoto M; Shiba Y; Ise H; Koyama J; Tagawa Y; Iwakura Y; Ikeda U
    Cardiovasc Res; 2008 Nov; 80(2):175-80. PubMed ID: 18791204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perivascular adipose tissue-secreted angiopoietin-like protein 2 (Angptl2) accelerates neointimal hyperplasia after endovascular injury.
    Tian Z; Miyata K; Tazume H; Sakaguchi H; Kadomatsu T; Horio E; Takahashi O; Komohara Y; Araki K; Hirata Y; Tabata M; Takanashi S; Takeya M; Hao H; Shimabukuro M; Sata M; Kawasuji M; Oike Y
    J Mol Cell Cardiol; 2013 Apr; 57():1-12. PubMed ID: 23333801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of apoptosis signal-regulating kinase 1 in injured artery and its critical role in neointimal hyperplasia.
    Izumi Y; Kim S; Yoshiyama M; Izumiya Y; Yoshida K; Matsuzawa A; Koyama H; Nishizawa Y; Ichijo H; Yoshikawa J; Iwao H
    Circulation; 2003 Dec; 108(22):2812-8. PubMed ID: 14638553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro.
    Sakata Y; Xiang F; Chen Z; Kiriyama Y; Kamei CN; Simon DI; Chin MT
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2069-74. PubMed ID: 15345511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.